Efficacy of Centanafadine SR as a Potential Smoking Cessation Treatment

NCT05066724 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: Centanafadine

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.